13F Holdings
中文EN

AMS AMERICAN SHARED HOSPITAL SERVICES

Services-Medical Laboratories · NYSE · SEC CIK 744825 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY4.9%
TTM net income YoY-5.6%
TTM EPS YoY0.0%
Revenue 3-yr CAGR14.3%
Net income 3-yr CAGR—

Margins

Gross margin16.7%
Operating margin-13.0%
Net margin-7.7%
FCF margin22.4%
EBITDA margin4.2%

Returns

ROE-10.1%
ROA-4.2%
ROIC (approx.)-9.0%
Asset turnover0.55x

Leverage & solvency

Liabilities / assets52.7%
Debt / equity0.77x
Current ratio0.81x
Interest coverage-2.85x

Cash quality & payout

Operating cash flow / net income-2.15x
Accruals ratio-13.3%
Payout ratio—
Capex / revenue-5.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$28.08M$28.34M$21.32M$19.75M$17.63M
Cost of revenue$23.02M$19.16M$11.98M$11.36M$10.90M
Gross profit$5.06M$9.19M$9.34M$8.38M$6.73M
SG&A expense$7.08M$7.41M$7.02M$5.14M$4.53M
Operating income-$3.59M-$2.81M$270,000$2.43M$1.35M
Interest expense$1.57M$1.50M$1.11M$806,000$739,000
Pretax income-$3.22M$1.24M$696,000$2.52M$947,000
Income tax-$493,000-$295,000$431,000$963,000$269,000
Net income-$1.55M$2.19M$610,000$1.33M$194,000
EBITDA$2.13M$3.37M$5.43M$7.21M$6.32M
EPS (basic)-0.230.340.100.210.03
EPS (diluted)-0.230.330.100.210.03
Weighted avg. shares (diluted)6.62M6.70M6.39M6.30M6.06M
Balance sheet
Cash & equivalents$3.46M$11.03M$13.69M$12.34M$8.14M
Receivables$10.52M$11.61M$4.34M$3.80M$4.21M
Current assets$17.72M$26.26M$20.46M$18.72M$15.09M
PP&E, net—$72.85M$81.23M$74.24M—
Goodwill$1.26M$1.26M$1.26M$1.26M$1.26M
Intangibles$78,000$78,000$78,000$78,000$78,000
Total assets$55.48M$60.20M$48.16M$43.96M$45.43M
Current liabilities$23.44M$10.40M$10.78M$5.17M$5.89M
Short-term debt$17.29M$2.84M$2.08M$1.26M$1.08M
Long-term debt$0$17.34M$11.04M$12.21M$14.32M
Total debt$17.29M$20.18M$13.12M$13.47M$15.40M
Total liabilities$27.79M$30.17M$21.88M$18.33M$21.19M
Shareholders' equity$24.03M$25.18M$22.62M$21.62M$19.89M
Net debt$13.83M$9.16M-$565,000$1.13M$7.26M
Shares outstanding6.58M6.42M6.30M6.18M6.05M
Cash flow statement
Operating cash flow$3.10M$167,000$5.72M$7.24M$6.27M
Capital expenditure$7.63M$7.94M$6.27M$388,000$1.67M
Free cash flow-$4.54M-$7.77M-$555,000$6.85M$4.59M
Investing cash flow-$7.63M-$7.11M-$6.27M-$388,000-$1.67M
Financing cash flow-$3.03M$4.41M$1.91M-$2.66M-$655,000
Depreciation & amortization$5.71M$6.17M$5.17M$4.78M$4.97M
Stock-based compensation$404,000$373,000$389,000$399,000$420,000

Free plan shows the latest 5 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.